Related Experiment Video
Updated: Jun 19, 2026
08:47
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
Membrane microdomains and insulin resistance.
1Division of Glycopathology, Institute of Molecular Biomembranes and Glycobiology, Tohoku Pharmaceutical University, Aoba-ku, Sendai, Miyagi, Japan. jin@tohoku-pharm.ac.jp
FEBS Letters
|October 14, 2009
Summary
Type 2 diabetes and insulin resistance may stem from membrane microdomain disorders involving gangliosides. A novel "membrane microdomain ortho-signaling therapy" is proposed to target these molecular pathways.
Area of Science:
- Biochemistry
- Cell Biology
- Endocrinology
Background:
- Metabolic disorders, including type 2 diabetes, are increasingly recognized as complex diseases.
- The role of cell membrane structure and function in metabolic regulation is an emerging area of research.
- Gangliosides, key components of cell membranes, are implicated in various cellular processes.
Purpose of the Study:
- To investigate the hypothesis that type 2 diabetes and insulin resistance are caused by membrane microdomain disorders due to aberrant ganglioside expression.
- To elucidate the molecular pathogenesis of type 2 diabetes and insulin resistance at the level of microdomain interactions.
- To propose a novel therapeutic strategy targeting these membrane microdomains.
Main Methods:
- Analysis of molecular interactions within membrane microdomains.
- Focus on the interplay between the insulin receptor and gangliosides.
- Investigation of aberrant ganglioside expression in the context of metabolic dysfunction.
Main Results:
- Demonstration of the molecular pathogenesis of type 2 diabetes and insulin resistance.
- Identification of specific interactions between the insulin receptor and gangliosides in microdomains.
- Evidence supporting the link between aberrant ganglioside expression and disease development.
Conclusions:
- Type 2 diabetes and insulin resistance can be conceptualized as membrane microdomain disorders.
- Aberrant ganglioside expression significantly contributes to the pathogenesis of these metabolic conditions.
- Membrane microdomain ortho-signaling therapy presents a promising new therapeutic avenue.
Related Concept Videos
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:18Membrane Domains
The membrane domains concentrate specific lipids and proteins at one place within the membrane, which helps in cell signaling, adhesion, and other critical cellular processes. These domains can differ in size, composition, function, and lifespan.
Protein Domains
The membrane comprises a group of distinct proteins responsible for carrying out a cell's specific function. For example, the plasma membrane of the human sperm, or a single germ cell, contains a unique set of proteins in the anterior...
Protein Domains
The membrane comprises a group of distinct proteins responsible for carrying out a cell's specific function. For example, the plasma membrane of the human sperm, or a single germ cell, contains a unique set of proteins in the anterior...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:05Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
00:59Mechanisms of Membrane Domain Formation
Different physical properties of lipids and proteins allow them to localize and form distinct islands or domains in the membrane. Some membrane domains are formed due to protein-protein interactions, whereas others are formed due to the presence of specific lipids such as sphingolipids and sterols—for example, large proteins, such as bacteriorhodopsin, aggregate and create distinct domains.
Another mechanism for membrane domain formation involves membrane proteins interacting with cytoskeletal...
Another mechanism for membrane domain formation involves membrane proteins interacting with cytoskeletal...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...